Clinical Trials Browser

Phase 2 × Febrile Neutropenia × pegfilgrastim × Clear all

NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Phase 2 Terminated

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia